YIH
DICE

Y-Intercept (HK)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Y-Intercept (HK)’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,098
Closed -$203K – 1840
2023
Q1 		$203K Buy
+7,098
New +$210K 0.02% 964

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Y-Intercept (HK)'s DICE Position: Q2 2023 in Review

Y-Intercept (HK) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 7,098 shares — an estimated $203K sold.

Y-Intercept (HK) first reported a position in DICE in Q1 2023 and held it in 1 quarter. The position peaked at $203K in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Y-Intercept (HK) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 7,098 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $203K.
  • Y-Intercept (HK) first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Y-Intercept (HK)'s DICE Therapeutics, Inc. Common Stock position peaked at $203K in Q1 2023.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Y-Intercept (HK)'s 13F filing for Q2 2023, filed 14 Aug 2023.